Vireo Growth (VREOF) EPS (Basic) (2020 - 2026)

Vireo Growth (VREOF) reported EPS (Basic) of -$0.02 for Q1 2026, down 257.18% on a YoY basis from $0.01 in Q1 2025, and up 54.7% sequentially from -$0.05 in Q4 2025.

Vireo Growth (VREOF) EPS (Basic) (2020 - 2026) Analysis & Trends

Vireo Growth (VREOF) has 7 years of EPS (Basic) data on file, last reported at -$0.02 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Basic) fell 257.18% year-over-year to -$0.02; the trailing twelve-month figure through Mar 2026 stood at -$0.05 (down 196.59% YoY), and the FY2025 full-year result was -$0.11, down 222.35% from the prior year.
  • EPS (Basic) advanced to -$0.02 in Q1 2026, from -$0.05 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.03 in Q2 2024 to a low of -$0.14 in Q1 2022.
  • A 5-year average of -$0.02 and a median of -$0.02 in 2026 frame the typical range for EPS (Basic).
  • Across the five-year window, EPS (Basic) jumped 153.84% in 2024 and sank 297.17% in 2025, its largest moves.
  • Tracing VREOF's EPS (Basic) over 5 years: stood at -$0.07 in 2022, then jumped by 136.42% to $0.03 in 2023, then retreated by 11.71% to $0.02 in 2024, then slumped by 297.17% to -$0.05 in 2025, then soared by 54.7% to -$0.02 in 2026.
  • Business Quant data shows VREOF's EPS (Basic) at -$0.02 in Q1 2026, -$0.05 in Q4 2025, and $0.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 0.32
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 1.42
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -1.49
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 6.32
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 0.15
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.97
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 0.11
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn -0.02

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.02
Dec 31, 2025 -0.05
Sep 30, 2025 0.00
Jun 30, 2025 0.01
Mar 31, 2025 0.01
Dec 31, 2024 0.02
Sep 30, 2024 0.02
Jun 30, 2024 0.03
Mar 31, 2024 0.03
Dec 31, 2023 0.03
Sep 30, 2023 -0.04
Jun 30, 2023 -0.06
Mar 31, 2023 -0.07
Dec 31, 2022 -0.07
Sep 30, 2022 -0.07
Jun 30, 2022 -0.05
Mar 31, 2022 -0.14
Dec 31, 2021 -0.11
Sep 30, 2021 -0.05
Jun 30, 2021 -0.06